Your AI Product May Need Verified Access, Not Just a Login
The next important feature in some AI products will not be a smarter model.
It will be deciding who gets access to which capability, for what purpose, and under what conditions.
Anthropic made that pattern explicit on September 17 with its Life Sciences Verification Program. The program gives vetted teams access to AI capabilities for work such as drug discovery, research biology, clinical development, and manufacturing. Applicants are reviewed for research credentials, security standards, and ethical oversight. Higher-risk work requires additional project-level approval.
OpenAI and Google DeepMind have described similar trusted-access approaches for advanced life-sciences systems.
This is not only a safety story for frontier labs. It is a product lesson for founders building AI in healthcare, finance, legal work, cybersecurity, industrial operations, and other high-stakes markets.
A login proves that someone has an account. Verified access establishes what that person or organization is qualified and authorized to do.
One product may need several capability boundaries
Most early AI products have simple access control:
- free or paid;
- user or administrator;
- trial or active customer.
That may be enough for a low-risk writing tool. It becomes weak when the product can influence a medical decision, inspect sensitive infrastructure, prepare a regulated filing, or take action inside a business system.
Anthropic’s program separates standard access for broad professional life-sciences work from higher-risk access tied to a specific project. Standard grants apply to teams and renew annually. High-risk grants apply to individual projects and renew every six months. Other safeguards remain in place.
The exact structure will differ for your product. The useful principle is that capability does not need to be all-or-nothing.
You might separate access by:
- role: analyst, reviewer, licensed professional, administrator;
- data: public information, internal records, regulated records;
- action: draft, recommend, approve, execute;
- risk: routine case, exception, high-impact decision;
- scope: one customer, one facility, one project, or one jurisdiction.
This creates a more useful question than, “Should the customer have access?”
Ask, “What is the safest useful capability this customer should have right now?”
Verification can strengthen the product, not only restrict it
Founders often treat verification as friction added by compliance.
That misses the upside.
A verified user can receive a product designed around their real professional context. The workflow can use the right terminology, expose the right tools, apply the right review process, and avoid interrupting legitimate work with broad restrictions meant for anonymous users.
OpenAI’s GPT-Rosalind-5.5 deployment shows this tradeoff. OpenAI describes the model as a life-sciences research system available to approved organizations with legitimate research uses, governance, oversight, and enterprise security. The model relies on trusted access and deployment controls as part of its safeguard structure.
Google DeepMind and Isomorphic Labs describe granting trusted researchers access to advanced systems for work including vaccine and medical countermeasure design. Their approach combines expert access with threat modeling, evaluations, mitigations, and monitoring.
The common pattern is not “verify everyone because risk is scary.”
It is “use evidence about the user, organization, and intended work to make a more capable product available responsibly.”
For a domain-expert founder, that can become a competitive advantage. You may understand which credentials matter, which use cases are legitimate, which actions require a second reviewer, and which warning signs indicate misuse. A general software team may not.
Build the access model before the advanced feature
Do not wait until enterprise customers ask for a permissions matrix.
Before you release a high-impact capability, write a one-page access model:
- Name the capability. What can the product do that creates meaningful value or risk?
- Define the qualified user. Which role, training, license, contract, or organizational control should be present?
- State the approved purpose. What work is allowed, and what work falls outside the product’s intended use?
- Limit the scope. Is access tied to a team, project, dataset, customer account, or time window?
- Choose the evidence. What must the applicant provide, and who reviews it?
- Set the renewal rule. What change should trigger re-verification?
- Plan the response. What happens when use moves outside the approved scope?
Keep the first version narrow.
If you are building an AI product for commercial insurance, do not begin by verifying every possible professional role. Start with the one workflow you understand. Perhaps brokers can draft a submission summary, senior reviewers can approve exceptions, and only administrators can connect a carrier system.
If you are building for clinical operations, the first boundary might separate document preparation from clinical judgment. If you are building for cybersecurity, it might separate passive analysis from actions that touch a live environment.
The access model should follow the real workflow, not a generic permission template.
Monitoring completes the access decision
Verification is not a permanent guarantee of safe use.
Accounts can be compromised. Employees can change roles. A legitimate project can drift. An agent can take an unexpected sequence of actions.
Anthropic says its life-sciences program ties access to the use cases described in each grant application, then monitors for activity outside that stated scope. It also names account compromise, insider threats, and agent misuse as risks the program is designed to address.
Your product may not need that level of infrastructure on day one. It still needs a feedback loop.
Track signals that match the risk:
- use of capabilities outside the person’s normal role;
- unusual volume or repeated retries;
- attempts to cross customer or project boundaries;
- actions taken without the expected review step;
- changes to connected data sources or permissions;
- repeated requests that the product refuses or escalates.
Then decide who reviews those signals and what they can do. A dashboard no one owns is not a safeguard.
The goal is not surveillance for its own sake. It is to confirm that the conditions used to grant access still hold.
Domain expertise can become the trust layer
Model capability is spreading quickly. Trustworthy deployment is still specific to the market.
That creates an opening for experienced professionals. You know what qualified practice looks like. You know which actions carry real consequences. You know where a second set of eyes belongs and when an exception needs to stop the workflow.
Turn that judgment into product rules:
- who can use the capability;
- what evidence grants access;
- what the approved scope includes;
- where human review is required;
- which signals trigger investigation or removal.
That is more than compliance. It is product design built from domain knowledge.
If you want help turning a workflow you understand into a focused AI product and a 12-week path to launch, book a strategy call. That is the work we do inside AI Product Accelerator.